Yamada, Iwao

In 1996, Mr. Iwao Yamada enrolled to obtain a Masters degree in the Department of Applied Chemistry, Faculty of Science and Technology, Keio University in Japan. He learned organic synthetic skills along with separation and purification techniques of organic compounds as well as analytical skills using 1H-/13C-NMR.

After graduating in 1998, Mr. Yamada started to work in an ADME group within the ADME department, Tokyo New Drug Research Laboratories, Kowa Company, Ltd. in Japan and, in 2007, became a Chief Lab Researcher. He utilized LC/MS/MS techniques to determine drug concentrations in animal plasma to estimate exposure levels to assure that these drugs would be safe for use in humans. He also gained experience in using in vivo animal absorption studies. In 2010, he began to work with the atherosclerosis research group in the pharmacology department and received training in pharmacology and biology research techniques.

Mr. Yamada joined the CICS in May 2011. Since then he has been conducting experiments about the signaling pathway of endothelial lipase and inhibition of this pathway by pitavastatin, to determine whether this inhibition will lead to increased HDL levels in human plasma.

Mr. Yamada’s personal goal in the next phase of his career is to obtain a Ph.D. degree in pharmacology and to have the skills necessary to become a scientific generalist with the tools to develop new drugs efficiently.

Publications